Clinical trial
Efficacy of Adjuvant Mitotane Treatment in Prolonging Recurrence-free Survival in Patients With Adrenocortical Carcinoma at Low-intermediate Risk of Recurrence
NCT00777244 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Adjuvant Mitotane Treatment in Prolonging Recurrence-free Survival in Patients With Adrenocortical Carcinoma at Low-intermediate Risk of Recurrence
- Lead sponsor
- University of Turin, Italy
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 30, 2008
- Completion date
- December 31, 2020
- Enrollment
- 200 (estimated)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.